Haegarda (C1 esterase inhibitor Subcutaneous, human) — United Healthcare
routine prophylaxis to prevent Hereditary Angioedema (HAE) attacks
Initial criteria
- Diagnosis of hereditary angioedema (HAE)
- For prophylaxis against HAE attacks
- Not used in combination with other products indicated for prophylaxis against HAE attacks (e.g., Cinryze, Takhzyro, Orladeyo)
- age ≥ 6 years
Approval duration
12 months